JNJ-1330
- Generic Name
- JNJ-1330
A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 42
- Registration Number
- NCT05014360
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸City of Hope, Duarte, California, United States
🇫🇷Hopital Edouard Herriot - CHU Lyon, Lyon, France
A Study of JNJ-64251330 in Healthy Participants
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2022-12-02
- Lead Sponsor
- Janssen Research & Development, LLC
- Target Recruit Count
- 36
- Registration Number
- NCT04552197
- Locations
- 🇧🇪
Clinical Pharmacology Unit, Merksem, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath